Estadiamento Cirúrgico no Câncer do Ovário
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n2.3240Keywords:
Ovary Carcinoma, Surgical Staging, Limphnode MetastaseAbstract
At the National Cancer Institute of Milan, from 1975 to 1985, 201 patients with ovarian carcinoma, not previously treated with chemoterapy o, radioterapy, underwent complete staging laparotomy to establish the spread of the disease and to plan treatment. Surgical staging included: hysterectomy and bilateral salpingo-oophorectomy, omentectomy, apendectomy, retroperitoneal lymph node dissection and multiple biopsies. A total of 153 patients underwent preoperative clinical/instrumental staging including laparoscopy with diaphragmatic inspection and peritoneal washing, lymphography, coo trast enema and urography. In these cases, clinical understaging, in comparison to staging laparotomy, was observed in 41,9% in stage I, 44,4% in stage II and 7,9% in stage III. The sensibility of lymphography and laparoscopy versus pathological results was 79,6110 and 49,0%, respectively. Staging laparotomy is useful in understanding the process of spread in ovarian carcinoma, particularly, the formation of lymphnodal metastases in a neoplasm that is considered to be almost exclusively peritoneal in its dissemination. Lymph node metastases were detected in 16,301. at Stage I 18,1% stage II, 58,8% stage III and 46,1% stage IV. The data presented here confirm that surgical staging is the only correct method to establish the spread of disease in an apparently localized phase.
Downloads
References
Allan MS, Hertig AT. Carcinoma of the ovary. Am J Obstet Gynecol. 1949; 58: 640-653. DOI: https://doi.org/10.1016/S0002-9378(16)39219-5
Decker DG, Malkasian GO Jr,Taylor , WF. Prognostic importance of histologic grading in ovarian carcinoma. Boular J C III ed. ln: Symposium on Ovarian Carcinoma, National Cancer Institute Monograph 42. Washington. U.S. Government Printed Office. 1975: 0-11.
Russel P. The pathological assessment of ovarian neoplasma. Introduction to the common "epitheliai" tumors and analysis - of benign "epithelial" tumors. Pathology. 1979; 11: 5-26. DOI: https://doi.org/10.3109/00313027909063533
Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obst Gynecol. 1971; 110-773. DOI: https://doi.org/10.1016/0002-9378(71)90571-0
De Palo G, Musumeci A, Spinelli P. II Carcinoma ovarico: quasi uno sconosciuto. Argomenti di Oncologia. 1981; 2: 4 1-83.
Kaiistad P. Malignant tumors of ovary: Noerwegien experience - and protocois for management. Coppieson Ed. in: Gynecologic Oncology. New York: Springer Verlag. 1981 721 -730.
Whaton JJ, Herson J. Sugery for common epithelial tumors of the ovary. Cancer. 1981; 48: 582-589. DOI: https://doi.org/10.1002/1097-0142(19810715)48:1+<582::AID-CNCR2820481323>3.0.CO;2-C
Webb JJ. The role of staging procedures in therapy. 1983.
Abrams HR, Spiro A, Goidstein N. Metastases in carcinoma. Cancer. 1950; 3:74-85. DOI: https://doi.org/10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7
Bergman F. Carcinoma of the ovary. A clinicopathological study of 86 autopsied cases with special reference to mode of spread. Acta Obstet Gynec Scand. 1966; 45: 211-231. DOI: https://doi.org/10.3109/00016346609158447
Plenti AA, Friedman EA. Lymphatic system of the female genitalia. Philadelphia. W B Saunders Company. 1971.
Burghordt E, et al. Management of advanced ovarian Cancer EurJ Gynecol Oncol. 1984; 3: 155-159.
Sidney S, Chen et al. Prognostic significance of morphology - of tumor on retroperitoneal lymphonodes in epithelial carcinoma of the ovary. II correlation with survival. Gynecol Oncol 1984; 18: 94-99. DOI: https://doi.org/10.1016/0090-8258(84)90011-8
Dyson JL, et al. Factor, influencing survival in carcinoma of the ovary. BrJ Cancer. 1971; 25: 237-249. DOI: https://doi.org/10.1038/bjc.1971.30
Kottmeier HK. Anual Report on the results of treatment in Carcinoma of the uterus, vagina and ovary. Stockholm, 1976. DOI: https://doi.org/10.1016/0090-8258(76)90002-0
Sorbe B, et al. Importance of histologic grading in the prognosis of epitelial ovarian carcinoma. Obstetric Gynecol. 1982; 59: 576-582.
Greco FA, et al. Advanced ovarian cancer: Brief intensive combination chemotherapy and second-look operation. Obstet and Gynec. 1981; 58: 199-205.
Griffths CT. New developments in the surgical treatment of ovarian cancer. In: Surgery in Gynecological Oncology. 1984: 261 -274. DOI: https://doi.org/10.1007/978-94-009-6750-2_22
Musumeci R, Banfi A, Bolis G, et al. Lymphangiography in patients with ovarian epithelial cancer. Cancer 1977; 40: 1 444-49. DOI: https://doi.org/10.1002/1097-0142(197710)40:4<1444::AID-CNCR2820400414>3.0.CO;2-I
Delgado G. Chum B, Cagiar H. Paraaortic iimphadenectomy in gynecologic malignacies confined to the pelvis. Obst Gynecol 1977; 50:418.
Spinelli P, Luini A, Pizzete P, De Paio GM. Laparoscopy in staging and restaging of 95 patients with ovarian carcinoma. Tumori. 1979; 62: 493-502. DOI: https://doi.org/10.1177/030089167606200504
